skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Interactions of ozone and antineoplastic drugs on rat lung fibroblasts and Walker rat carcinoma cells

Journal Article · · Res. Commun. Chem. Pathol. Pharmacol.; (United States)
OSTI ID:5544777

Cultured rat lung fibroblasts (F-cells) and Walker rat carcinoma cells (WRC-cells) labeled with /sup 51/Cr were exposed to the following antitumor drugs alone or with O/sub 3/: carmustine (BCNU), doxorubicin (Dox), cisplatin (CPt), mitomycin C (Mit C) or vitamin K/sub 3/ (Vit K). Release of /sup 51/Cr (cell injury) was greater for F-cells than WRC-cells with any single treatment. Pretreatment with any drug (400 microM), except for Vit K with WRC-cells, did not significantly increase O/sub 3/-induced loss of /sup 51/Cr. Co-exposure of F-cells to drugs and O/sub 3/ resulted in a marked potentiation of O/sub 3/-induced injury with Vit K, and an inhibition with Dox.

Research Organization:
Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence
OSTI ID:
5544777
Journal Information:
Res. Commun. Chem. Pathol. Pharmacol.; (United States), Vol. 40:2
Country of Publication:
United States
Language:
English